Global University Venturing

IBM will help Ben-Gurion University of the Negev power a deep tech accelerator featuring an initial cohort of six spinouts.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Washington State University neurological drug developer has gone public after issuing 12 million shares priced at $17 each.

Cash Capital was among the investors for Baijiayun, creators of an online education and training platform tailored to delivering massively open online courses.

Inflazome, which advances University of Queensland and Trinity College Dublin research to develop treatments for inflammation, has been bought by Roche for $448m.

University of Chicago is among the limited partners for Kindred Capital’s second fund, which will invest in early-stage European startups.

The Dutch multi-university venture fund had targeted $70m for its latest fund but ended up attracting $82.5m from investors including Protix and Corbion.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

OSU's kidney dialysis technology provider has added about $36m to close its initial public offering, its shares having more than doubled in price.

Novo Ventures and Sanofi Ventures co-led a series C round for the cancer therapy developer, which builds on work at Amsterdam UMC.

Ghent University-founded rapid diagnostic test developer Antelope DX picked up Whitefund and existing investors to bring its funding total to $16.6m.